Cell-therapy for advanced kidney disease

Israeli biotech KidneyCure is developing personalized cell-therapy technology for treating advanced chronic kidney disease (CKD). An estimated 30 million adults in the US have CKD (most are undiagnosed) with 600,000 on dialysis.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.